BFC Planning, Inc.’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Sell
469
-1,406
-75% -$521K 0.01% 969
2026
Q1
$549K Sell
1,875
-51
-3% -$16.8K 0.02% 537
2025
Q4
$675K Buy
1,926
+1,351
+235% +$457K 0.03% 463
2025
Q3
$186K Sell
575
-1
-0.2% -$311 0.01% 696
2025
Q2
$224K Buy
576
+11
+2% +$4.42K 0.02% 597
2025
Q1
$246K Buy
565
+18
+3% +$7.23K 0.02% 531
2024
Q4
$202K Buy
+547
New +$229K 0.02% 612

Other funds holding ELV

BFC Planning, Inc.'s ELV Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Elevance Health (ELV) stake by 75% in Q2 2026, selling an estimated $521K and leaving 469 shares worth $182K. The position accounts for 0.01% of the portfolio, ranked #969.

BFC Planning, Inc. first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $675K in Q4 2025. 1,617 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BFC Planning, Inc. held 469 shares of Elevance Health worth $182K as of Q2 2026.
  • BFC Planning, Inc. sold 1,406 Elevance Health shares in Q2 2026, an estimated $521K.
  • Elevance Health made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #969 holding.
  • BFC Planning, Inc. first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Elevance Health position peaked at $675K in Q4 2025.
  • 1,617 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.